03778nam 2200625Ia 450 991082667490332120240418064811.01-281-32095-197866113209590-470-75714-00-470-75690-X(CKB)1000000000551268(EBL)351625(OCoLC)437218842(SSID)ssj0000262100(PQKBManifestationID)11191789(PQKBTitleCode)TC0000262100(PQKBWorkID)10269054(PQKB)10967100(MiAaPQ)EBC351625(Au-PeEL)EBL351625(CaPaEBR)ebr10232834(CaONFJC)MIL132095(EXLCZ)99100000000055126820010124d2002 uy 0engur|n|---|||||rdacontentrdamediardacarrierTreatment options in urological cancer[electronic resource] /edited by Jonathan Waxman1st ed.Malden, Mass. Blackwell Science20021 online resource (408 p.)Description based upon print version of record.0-632-05589-8 Includes bibliographical references and index.TREATMENT OPTIONS IN UROLOGICAL CANCER; Contents; Contributors; Preface; Part 1 Kidney Cancer; 1 The Molecular Biology of Kidney Cancer; 2 Cytokines and Angiogenesis Inhibitor Treatments; 3 Surgical Management of Metastatic Renal Cancer; Kidney Cancer: Commentary; Part 2 Bladder Cancer; 4 The Molecular Biology of Bladder Cancer; 5 Surgery for Advanced Bladder Cancer; 6 Chemotherapy and Bladder Cancer; 7 Treatment Options in Superficial (pTa/pT1/CIS) Bladder Cancer; Bladder Cancer: Commentary; Part 3 Prostate Cancer; 8 The Molecular Biology of Prostate Cancer9 Surgical Pathology of Prostate Cancer10 Prostate Radiotherapy; 11 Prostate Cancer: Immediate vs. Deferred Treatment; 12 Hormone Therapy of Prostate Cancer; 13 Chemotherapy in Hormone Refractory Prostate Cancer; 14 Radical Prostatectomy; 15 The Case against Radical Surgery for Early Prostate Cancer; Prostate Cancer: Commentary; Part 4 Testicular Cancer; 16 Genetics of Adult Male Germ Cell Tumours; 17 Surveillance, Chemotherapy, and Radiotherapy for Stage 1 Testicular Germ Cell Tumours; 18 Chemotherapy of Testicular Cancer; 19 Salvage Chemotherapy Regimens for Relapsing Germ Cell Cancer20 Surgery for Testicular CancerTesticular Cancer: Commentary; Part 5 Penile Cancer; 21 Viral Agents in the Development of Penile Cancer; 22 Current Concepts in the Management of Penile Cancer; Penile Cancer: Commentary; IndexCancer forms a large part of urological practice. Prostate cancer is the most significant and is the second most common cause of male cancer deaths with some 300,000 cases in the USA annually. Cancer of the bladder is also common. While treatment has been primarily surgical, recent years have seen an explosion of new drug therapies for urological cancers. All urologists, whether in training or in practice, need an up-to-date survey of the literature and key findings in this important and controversial field. This book takes each organ in turn (prostate, kidney, bladder, testis and penis) aGenitourinary organsCancerTreatmentCancerTreatmentGenitourinary organsCancerTreatment.CancerTreatment.616.99/4606616.9946Waxman Jonathan883266MiAaPQMiAaPQMiAaPQBOOK9910826674903321Treatment options in urological cancer1972950UNINA